L
Lyell Immunopharma D
D
LYEL
0.93030
USD
0.00
(0.38%)
مغلق
حجم التداول
6,626
الربح لكل سهم
-1
العائد الربحي
-
P/E
-1
حجم السوق
259,758,937
العنوان: Lyell Immunopharma
القطاع: Healthcare
الصناعة: Biotechnology
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.